References
Dunsmore KP. Intravenous immunoglobulin G therapy in fetal and neonatal alloimmune thrombocytopenia. BioDrugs 1997 Oct; 8(4): 265–72
Clark AL, Gall SA. Clinical uses of intravenous immunoglobulin in pregnancy. Am J Obstet Gynecol 1997 Jan; 176 Part 1: 241–53
Mueller-Eckhardt C, Grubert A, Weishart M, et al. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet 1989 Feb; 1: 363–6
Burrows RF, Kelton JG. Fetal thrombocytopenia. N Engl J Med 1993; 329: 1493–6
Bussel JB, Neonatal Immune Thrombocytopenia Study Group. Neonatal alloimmune thrombocytopenia (NAIT): a prospective case accumulation study [abstract]. Pediatr Res 1988; 23: 337A
Forestier F, Daffos F, Galacteros F, et al. Hematological values of 163 normal fetuses between 18 and 30 weeks of gestation. Pediatr Res 1986; 20: 342–6
Bussel JB, Berkowitz Rl, McFarland JG, et al. Antenatal treatment of neonatal alloimmune thrombocytopenia. N Engl J Med 1988 Nov; 319: 1374–8
Lynch L, Bussel JB, McFarland JG, et al. Antenatal treatment of alloimmune thrombocytopenia. Obstet Gynecol 1992; 80: 67–71
Rights and permissions
About this article
Cite this article
Intravenous immunoglobulin G makes antenatal therapy possible in neonatal alloimmune thrombocytopenia. Drugs Ther. Perspect 11, 6–8 (1998). https://doi.org/10.2165/00042310-199811100-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199811100-00002